Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2022-2025
Title: Charlotte Baker: Innovator in TRPV2 Antagonists
Introduction
Charlotte Baker is a prominent inventor based in Lisbon, Portugal. She has made significant contributions to the field of molecular medicine, particularly through her innovative work on TRPV2 antagonists. With a total of 2 patents, her research focuses on the therapeutic applications of Piperlongumine compounds.
Latest Patents
Charlotte's latest patents revolve around the discovery that Piperlongumine compounds, including analogues, derivatives, and prodrugs, act as reversible, allosteric antagonists of the transient receptor potential vanilloid 2 channel (TRPV2). These inventions provide methods for treating conditions characterized by TRPV2 expression, utilizing Piperlongumine compounds for effective treatment options.
Career Highlights
Throughout her career, Charlotte has worked with esteemed institutions such as the Instituto de Medicina Molecular João Lobo Antunes and the Gulbenkian Institute for Molecular Medicine. Her research has been pivotal in advancing the understanding of TRPV2 and its implications in various medical conditions.
Collaborations
Charlotte has collaborated with notable colleagues, including Tiago Rodrigues and João Conde, enhancing her research through shared expertise and innovative ideas.
Conclusion
Charlotte Baker's contributions to the field of molecular medicine, particularly through her patents on TRPV2 antagonists, highlight her role as a leading inventor. Her work continues to pave the way for new treatment methodologies, showcasing the importance of innovation in healthcare.